Page 3 - Peter Kaiser News Today

Approval based on the pivotal PULSAR and PHOTON trials in which EYLEA® HD demonstrated clinically equivalent vision gains to EYLEA (aflibercept) Injection...

An extension study found no cases of occlusive retinal vasculitis after 23,000 injections of pegcetacoplan, but a panel received more reports of the complication and dealt with conflicts of interest.

Chatting with some of the female riders who threw down on the Joyride course.

The California native rode fast and flew high through the Boneyard, as did women's champion Harriet Burbidge-Smith from Australia.

20 movies for your viewing pleasure.

/PRNewswire/ -- REGENXBIO Inc. (Nasdaq: RGNX) today announced that it will host a virtual investor day on July 11, 2023. During the event, members of...

The first passenger train has operated through the 33km Koralm tunnel in Austria, part of the new line under construction between Graz and Klagenfurt.

05.04.2023 - ALPHARETTA, Ga., April 05, 2023 (GLOBE NEWSWIRE) - Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space (SCS), today announced the ... Seite 1

Its a lifelong dream for Redington, whose grandfather founded the 1,000-mile race.

Operator: Good afternoon, ladies and gentlemen. Thank you for standing by and welcome to the Ocular Therapeutix Fourth Quarter and Year-End 2022 Earnings Conference Call.